Loading provider…
Loading provider…
Gastroenterology Physician in Coral Springs, FL
NPI: 1427393065Primary Practice Location
BETHESDA HOSPITAL EAST
2815 S Seacrest Blvd, Boynton Beach, FL
Primary Employer
South Florida Surgical Specialists LLC
sflsurgical.com
HQ Phone
Get M.D. Mrinal's Phone Numberphone_androidMobile
Get M.D. Mrinal's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2018 - 2026
PA State Medical License
2015 - 2018
MI State Medical License
2013 - 2017
NJ State Medical License
2011 - 2015

American Board of Internal Medicine
Gastroenterology
Allegheny Health Network Medical Education Consortium (AGH)
Fellowship • Gastroenterology
2015 - 2018
Rutgers Health/Robert Wood Johnson Medical School
Residency • Internal Medicine
2010 - 2013
New York Medical College
nymc.edu
Medical School
Until 2010
University of Miami
BS • 2001 - 2005
2001 - 2005
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 80 | 158 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 56 | 56 |
| 3 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 45 | 45 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 30 | 104 |
| 5 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 29 | 30 |
Ocular Radiation Threshold Projection Based off of Fluoroscopy Time During ERCP.
Lead Sponsor: Palatin Technologies, Inc
Intervention / Treatment: DRUG: PL8177 Placebo, DRUG: PL8177
Lead Sponsor: Vedanta Biosciences, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: VE303
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo IV, DRUG: Vedolizumab IV, DRUG: Placebo SC, DRUG: Mirikizumab SC, DRUG: Mirikizumab IV